UBE2A was determined to be expressed at higher levels in HCC specimens than in normal tissues with GEPIA (https://gepia.cancer-pku.cn/), and patients with lower UBE2A expression had longer survival according to KM Plotter (Fig. 5C). This evidence concerns the gene UBE2A and hepatocellular carcinoma.